XENETIC BIOSCIENCES, INC. Increase (Decrease) in Deferred Income Taxes
XENETIC BIOSCIENCES, INC. (XBIO) reported Increase (Decrease) in Deferred Income Taxes of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2022-03-22
- XENETIC BIOSCIENCES, INC. increase (decrease) in deferred income taxes for the quarter ending 2020-12-31 was $0.00.
- XENETIC BIOSCIENCES, INC. increase (decrease) in deferred income taxes for the quarter ending 2019-12-31 was $0.00.
- XENETIC BIOSCIENCES, INC. increase (decrease) in deferred income taxes for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- XENETIC BIOSCIENCES, INC. increase (decrease) in deferred income taxes for fiscal 2020 was $2.92M.
- XENETIC BIOSCIENCES, INC. increase (decrease) in deferred income taxes for fiscal 2019 was $0.00.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 9 month | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-22 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $2.92M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $2.92M 10-Q · filed 2020-11-12 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $0.00 10-K · filed 2021-03-16 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |